EUVIMEDEUVIMED entdecken
Crossref

Diosmin suppresses the proinflammatory mediators in lipopolysaccharide-induced RAW264.7 macrophages via NF-κB and MAPKs signal pathways

Mehmet Berkoz

General physiology and biophysics · 2019 · 38 (04) · 315-324

DOI: 10.4149/gpb_2019010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General physiology and biophysics, 2019. Verfasst von Mehmet Berkoz. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, 65080, Van, Turkey. mehmet_berkoz@yahoo.com. Hauptthemen laut MEDLINE: Lipopolysaccharides. Die Arbeit wurde bisher 40-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesAnimalsDiosminInflammation MediatorsMacrophagesMiceMitogen-Activated Protein KinasesNF-kappa BSignal Transduction

Substanzen

Inflammation MediatorsLipopolysaccharidesNF-kappa BDiosminMitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, 65080, Van, Turkey. mehmet_berkoz@yahoo.com.

Zitieren

APA

Berkoz, M. (2019). Diosmin suppresses the proinflammatory mediators in lipopolysaccharide-induced RAW264.7 macrophages via NF-κB and MAPKs signal pathways. General physiology and biophysics, 38(04), 315-324. https://doi.org/10.4149/gpb_2019010

Vancouver

Berkoz M. Diosmin suppresses the proinflammatory mediators in lipopolysaccharide-induced RAW264.7 macrophages via NF-κB and MAPKs signal pathways. General physiology and biophysics. 2019;38(04):315-324. doi:10.4149/gpb_2019010

BibTeX
@article{Berkoz2019,
  author = {Berkoz, Mehmet},
  title = {Diosmin suppresses the proinflammatory mediators in lipopolysaccharide-induced RAW264.7 macrophages via NF-κB and MAPKs signal pathways},
  journal = {General physiology and biophysics},
  year = {2019},
  volume = {38},
  number = {04},
  pages = {315--324},
  doi = {10.4149/gpb_2019010}
}
Kostenlos starten →